Lan, Nick S. R. http://orcid.org/0000-0002-7222-7314
Yeap, Bu B.
Fegan, P. Gerry
Green, Gillian
Rankin, James M.
Dwivedi, Girish
Funding for this research was provided by:
WA Health Research Fellowship
Article History
Received: 9 July 2020
Accepted: 18 September 2020
First Online: 21 September 2020
Compliance with ethical standards
:
: NSRL has received research funding and speaker honoraria from Sanofi as part of a Clinical Fellowship and conference support from Boehringer Ingelheim. BBY has received speaker honoraria and conference support from Sanofi, MSD, Boehringer Ingelheim, Lilly, AstraZeneca, Novo Nordisk and Takeda, and has participated on advisory committees for Sanofi, Lilly and Novartis. PGF has received speaker honoraria and conference support from Sanofi, MSD, Boehringer Ingelheim, Lilly, AstraZeneca and Novo Nordisk. GD reports 3 paid lectures from AstraZeneca, Pfizer, and Amgen not related to the topic in the manuscript. GD provides consultancy services to Artrya Pty Ltd. There was no pharmaceutical company involvement in the planning, conduct or publication of this research. No conflicts of interest to declare for other authors.
: Ethical approval was obtained from the Human Research Ethics Committee (RGS-3023). Participants provided written informed consent and the study was conducted according to the principles of the Declaration of Helsinki.